Michael V Relf1,2, Wei Pan1, Andrew Edmonds3, Catalina Ramirez4, Sathya Amarasekara1, Adaora A Adimora3,5. 1. School of Nursing, Duke University, Durham, NC. 2. Duke Global Health Institute, Duke University, Durham, NC. 3. Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC. 4. Women's Interagency HIV Study, The University of North Carolina at Chapel Hill, Chapel Hill, NC. 5. School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Abstract
BACKGROUND: Women represent 23% of all Americans living with HIV. By 2020, more than 70% of Americans living with HIV are expected to be 50 years and older. SETTING: This study was conducted in the Southern United States-a geographic region with the highest number of new HIV infections and deaths. OBJECTIVE: To explore the moderating effect of age on everyday discrimination (EVD); group-based medical (GBM) distrust; enacted, anticipated, internalized HIV stigma; depressive symptoms; HIV disclosure; engagement in care; antiretroviral medication adherence; and quality of life (QOL) among women living with HIV. METHODS: We used multigroup structural equation modeling to analyze baseline data from 123 participants enrolled at the University of North Carolina at Chapel Hill site of the Women's Interagency HIV Study during October 2013-May 2015. RESULTS: Although age did not moderate the pathways hypothesized, age had a direct effect on internalized stigma and QOL. EVD had a direct effect on anticipated stigma and depressive symptoms. GBM distrust had a direct effect on depressive symptoms and a mediated effect through internalized stigma. Internalized stigma was the only form of stigma directly related to disclosure. Depressive symptoms were a significant mediator between GBM, EVD, and internalized stigma reducing antiretroviral therapy medication adherence, engagement in care, and QOL. CONCLUSIONS: EVD, GBM, and internalized stigma adversely affect depressive symptoms, antiretroviral therapy medication adherence, and engagement in care, which collectively influence the QOL of women living with HIV.
BACKGROUND:Women represent 23% of all Americans living with HIV. By 2020, more than 70% of Americans living with HIV are expected to be 50 years and older. SETTING: This study was conducted in the Southern United States-a geographic region with the highest number of new HIV infections and deaths. OBJECTIVE: To explore the moderating effect of age on everyday discrimination (EVD); group-based medical (GBM) distrust; enacted, anticipated, internalized HIV stigma; depressive symptoms; HIV disclosure; engagement in care; antiretroviral medication adherence; and quality of life (QOL) among women living with HIV. METHODS: We used multigroup structural equation modeling to analyze baseline data from 123 participants enrolled at the University of North Carolina at Chapel Hill site of the Women's Interagency HIV Study during October 2013-May 2015. RESULTS: Although age did not moderate the pathways hypothesized, age had a direct effect on internalized stigma and QOL. EVD had a direct effect on anticipated stigma and depressive symptoms. GBM distrust had a direct effect on depressive symptoms and a mediated effect through internalized stigma. Internalized stigma was the only form of stigma directly related to disclosure. Depressive symptoms were a significant mediator between GBM, EVD, and internalized stigma reducing antiretroviral therapy medication adherence, engagement in care, and QOL. CONCLUSIONS:EVD, GBM, and internalized stigma adversely affect depressive symptoms, antiretroviral therapy medication adherence, and engagement in care, which collectively influence the QOL of women living with HIV.
Authors: Bulent Turan; Anna Joy Rogers; Whitney S Rice; Ghislaine C Atkins; Mardge H Cohen; Tracey E Wilson; Adaora A Adimora; Daniel Merenstein; Adebola Adedimeji; Eryka L Wentz; Igho Ofotokun; Lisa Metsch; Phyllis C Tien; Mallory O Johnson; Janet M Turan; Sheri D Weiser Journal: AIDS Behav Date: 2017-12
Authors: Victoria C Seghatol-Eslami; Heather E Dark; James L Raper; Michael J Mugavero; Janet M Turan; Bulent Turan Journal: J Acquir Immune Defic Syndr Date: 2017-01-01 Impact factor: 3.731
Authors: Carmen H Logie; Ying Wang; Ashley Lacombe-Duncan; Anne C Wagner; Angela Kaida; Tracey Conway; Kath Webster; Alexandra de Pokomandy; Mona R Loutfy Journal: Prev Med Date: 2017-12-22 Impact factor: 4.018
Authors: Medha Vyavaharkar; Linda Moneyham; Sara Corwin; Ruth Saunders; Lucy Annang; Abbas Tavakoli Journal: J Assoc Nurses AIDS Care Date: 2009-10-30 Impact factor: 1.354
Authors: Ingrid T Katz; Annemarie E Ryu; Afiachukwu G Onuegbu; Christina Psaros; Sheri D Weiser; David R Bangsberg; Alexander C Tsai Journal: J Int AIDS Soc Date: 2013-11-13 Impact factor: 5.396
Authors: Ning He; Charles M Cleland; Marya Gwadz; Dawa Sherpa; Amanda S Ritchie; Belkis Y Martinez; Linda M Collins Journal: Sage Open Date: 2021-12-01
Authors: Amie Koch; Tiarney D Ritchwood; Donald E Bailey; Courtney Ellis Caiola; Adaora A Adimora; Catalina Ramirez; Lauren Holt; Ragan Johnson; Kara McGee; Jacquelyn M McMillian-Bohler; Schenita D Randolph; Michael V Relf Journal: J Assoc Nurses AIDS Care Date: 2022 Mar-Apr 01 Impact factor: 1.809
Authors: Donald E Bailey; Courtney Caiola; Adaora A Adimora; Catalina Ramirez; Lauren Holt; Ragan Johnson; Amie Koch; Kara McGee; Jacquelyn M McMillian-Bohler; Schenita D Randolph; Tiarney D Ritchwood; Michael V Relf Journal: J Assoc Nurses AIDS Care Date: 2021-08-04 Impact factor: 1.809
Authors: Michael V Relf; William L Holzemer; Lauren Holt; Laura Nyblade; Courtney Ellis Caiola Journal: J Assoc Nurses AIDS Care Date: 2021 May-Jun 01 Impact factor: 1.809
Authors: Lunthita M Duthely; Alex P Sanchez-Covarrubias; Varsha Prabhakar; Megan R Brown; Tanya E S Thomas; Emily K Montgomerie; JoNell E Potter Journal: Health Equity Date: 2021-09-24
Authors: Morgan M Philbin; Carrigan L Parish; Elizabeth N Kinnard; Sarah E Reed; Deanna Kerrigan; Maria L Alcaide; Mardge H Cohen; Oluwakemi Sosanya; Anandi N Sheth; Adaora A Adimora; Jennifer Cocohoba; Lakshmi Goparaju; Elizabeth T Golub; Margaret Fischl; Lisa R Metsch Journal: J Acquir Immune Defic Syndr Date: 2020-07-01 Impact factor: 3.771